Meag Munich Ergo’s Ambev ABEV Stock Holding History

Meag Munich Ergo’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-319,444	Closed	-$1.59M	–	317
2016 Q4	$1.59M	Hold	319,444	–	–	0.07%	219
2016 Q3	$1.93M	Buy	+319,444	New	+$1.91M	0.1%	190
2016 Q2	–	Sell	-275,000	Closed	-$1.43M	–	176
2016 Q1	$1.43M	Hold	275,000	–	–	0.07%	184
2015 Q4	$1.25M	Hold	275,000	–	–	0.06%	179
2015 Q3	$1.21M	Hold	275,000	–	–	0.06%	176
2015 Q2	$1.69M	Hold	275,000	–	–	0.09%	160
2015 Q1	$1.58M	Hold	275,000	–	–	0.08%	162
2014 Q4	$1.71M	Hold	275,000	–	–	0.08%	178
2014 Q3	$1.79M	Hold	275,000	–	–	0.08%	172
2014 Q2	$1.93M	Hold	275,000	–	–	0.08%	171
2014 Q1	$2.04M	Hold	275,000	–	–	0.15%	139
2013 Q4	$2.01M	Buy	+275,000	New	+$2.01M	0.12%	167

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Meag Munich Ergo's ABEV Position: Q1 2017 in Review

Meag Munich Ergo sold out of Ambev (ABEV) in Q1 2017, closing a stake of 319,444 shares — an estimated $1.59M sold.

Meag Munich Ergo first reported a position in ABEV in Q4 2013 and held it in 12 quarters. The position peaked at $2.04M in Q1 2014. 293 funds tracked by Wall St. Rank hold ABEV as of Q1 2017.

Meag Munich Ergo reported no remaining Ambev position as of Q1 2017 after selling out during the quarter.
Meag Munich Ergo sold 319,444 Ambev shares in Q1 2017, an estimated $1.59M.
Meag Munich Ergo first reported a position in Ambev in Q4 2013 and held it in 12 quarters.
Meag Munich Ergo's Ambev position peaked at $2.04M in Q1 2014.
293 funds tracked by Wall St. Rank held Ambev as of Q1 2017.

Based on Meag Munich Ergo's 13F filing for Q1 2017, filed 10 May 2017.